Homepage
Catalog of Screening Compounds Screening Libraries Focused and Target Libraries Active Reference Sets Diversity Libraries
Screening Compounds Building blocks
Drug Discovery Services Custom Chemistry Medicinal chemistry In silico Drug Design (CADD) Discovery Biology Animal Models Toxicology and Safety ADME, DMPK Chemistry, Manufacturing and Controls
Company News & Media Contact us For suppliers Trends in discovery compounds
Homepage > Company > Media > Pharma News > 2016

Pharma News, 2016

Single protein may hold secret to treating Parkinson's disease and more
Single protein may hold secret to treating Parkinson's disease and more
New details learned about a key cellular protein could lead to treatments for neurodegenerative diseases, such as Parkinson's, Huntington's, Alzheimer's, and amyotrophic lateral sclerosis ...
Ancient Chinese medicine can help fight TB: Study
Ancient Chinese medicine can help fight TB: Study
New York.
Seattle Genetics Announces Clinical Hold on Several Phase 1 Trials of Vadastuximab Talirine (SGN-CD33A)
Seattle Genetics Announces Clinical Hold on Several Phase 1 Trials of Vadastuximab Talirine (SGN-CD33A)
BOTHELL, Wash.
FDA approves first drug for spinal muscular atrophy
FDA approves first drug for spinal muscular atrophy
The U.
Dipexium shares soar as merger focused on Aspertec is announced
Dipexium shares soar as merger focused on Aspertec is announced
Dipexium Pharmaceuticals (Nasdaq.
MS breakthrough: Doctors hail the discovery of a 'landmark' drug that alters the immune system
MS breakthrough: Doctors hail the discovery of a 'landmark' drug that alters the immune system
A 'landmark' drug to treat multiple sclerosis has undergone successful trials showing its ability to slow damage to the brain.
With billions at stake, will biosims finally make a mark in the U.S. in 2017?
With billions at stake, will biosims finally make a mark in the U.S. in 2017?
Biosimilars have already taken hold in Europe, with Celltrion's Remicade copy, for one, wreaking havoc on the branded med's sales.
Senate proposes incentivizing generic drugmakers to help control price hikes
Senate proposes incentivizing generic drugmakers to help control price hikes
After a yearlong investigation into rising drug prices, the U.
Biogen board approves spin-off of hemophilia business
Biogen board approves spin-off of hemophilia business
The board of directors of US biotech Biogen (Nasdaq.
Bristol-Myers Squibb selects CEO Giovanni Caforio as new chairman
Bristol-Myers Squibb selects CEO Giovanni Caforio as new chairman
Bristol-Myers Squibb announced Wednesday that CEO Giovanni Caforio will become chairman affective May 2 next year.
Novel Alzheimer's drug restores memory loss, prolongs life in mice
Novel Alzheimer's drug restores memory loss, prolongs life in mice
Advancing the fight against Alzheimer's disease, scientists have in a breakthrough study, identified a new drug target that could not only improve symptoms of brain degeneration, but also extend t...
Allergan to buy Acelity's tissue unit LifeCell for $2.9 billion
Allergan to buy Acelity's tissue unit LifeCell for $2.9 billion
Drugmaker Allergan Plc said on Tuesday it would buy LifeCell, a regenerative medicine unit owned by privately held Acelity LP Inc, for $2.
Catalog of Screening Compounds Screening Libraries Screening Compounds Building blocks
Drug Discovery Services News & Media Contact us
Payment systems
Policies & Terms     ©2023 ChemDiv     ChemistryOnDemand